Albusomatropin

DB12950InvestigationalProtein Based Therapies

Albusomatropin has been used in trials studying the treatment of Growth Hormone-Deficiency and Growth Hormone Deficiency.

Mechanism
Curator reviewed
Also known as
HUMAN SERUM ALBUMIN FUSED TO THE N-TERMINUS OF GROWTH HORMONE · RECOMBINANT HUMAN ALBUMIN-RECOMBINANT HUMAN GROWTH HORMONE FUSION PROTEIN · recombinant human serum albumin human growth hormone · SOMATROPIN-ALBUMIN FUSION PROTEIN
Code names
TV-1106

Resolves to

Compound
UNII88C1D8R8JWCAS1613273-96-3
Targets
P10912GHR

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
282Drug interactionsStructured to mechanism, not free text
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Albusomatropin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In